Patents by Inventor Wayne P. Fitzmaurice

Wayne P. Fitzmaurice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110111413
    Abstract: The present invention relates to codon optimization utilizing DNA shuffling. A method of producing gene sequences optimized for a desired functional property is described involving synthesizing a library of parental codon variant genes encoding some or all codon choices at some or all amino acid positions of a gene, reassorting the variant codons among the parental codon variant genes using DNA shuffling thereby forming progeny codon variant genes, expressing the progeny codon variant genes in a host; and screening or selecting for progeny codon variant genes encoding a desired functional property.
    Type: Application
    Filed: November 23, 2010
    Publication date: May 12, 2011
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice, Andrew A. Vaewhongs
  • Patent number: 7838219
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3? to 5? exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: November 23, 2010
    Assignee: Novici Biotech LLC
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice, Andrew A. Vaewhongs
  • Patent number: 7833759
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3? to 5? exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: November 16, 2010
    Assignee: Novici Biotech LLC
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice
  • Patent number: 7582423
    Abstract: We describe here an in vitro method of redistributing sequence variations between non-identical polynucleotide sequences, by making a heteroduplex polynucleotide from two non-identical polynucleotides; introducing a nick in one strand at or near a base pair mismatch site; removing mismatched base(s) from the mismatch site where the nick occurred; and using the opposite strand as template to replace the removed base(s) with bases that complement base(s) in the first strand. By this method, information is transferred from one strand to the other at sites of mismatch.
    Type: Grant
    Filed: October 25, 2002
    Date of Patent: September 1, 2009
    Assignee: Novici Biotech LLC
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice
  • Patent number: 7235386
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3? to 5? exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: June 26, 2007
    Assignee: Large Scale Biology Corporation
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice
  • Patent number: 7217514
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3? to 5? exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: May 15, 2007
    Assignee: Large Scale Biology Corporation
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice
  • Patent number: 7132588
    Abstract: The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183 kDa replicase proteins further characterized in its ability tostabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein, cells transformed with the vectors, and host plants infected by the viral vectors.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: November 7, 2006
    Assignee: Large Scale Biology Corporation
    Inventors: Wayne P. Fitzmaurice, Gregory P. Pogue, John A. Lindbo
  • Patent number: 7056740
    Abstract: We describe here restriction endonucleases and their uses. Restriction endonucleases are useful in finding single nucleotide polymorphisms. They are also useful in an in vitro method of redistributing sequence variations between non-identical polynucleotide sequences.
    Type: Grant
    Filed: January 31, 2003
    Date of Patent: June 6, 2006
    Assignee: Large Scale Biology Corporation
    Inventors: Hal S. Padgett, Andrew A. Vaewhongs, Fakhrieh S. Vojdani, Mark L. Smith, John A. Lindbo, Wayne P. Fitzmaurice
  • Publication number: 20040180352
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3′ to 5′ exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Application
    Filed: August 8, 2003
    Publication date: September 16, 2004
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice, Andrew A. Vaewhongs
  • Publication number: 20040142433
    Abstract: We describe here an in vitro method of redistributing sequence variations between non-identical polynucleotide sequences, by making a heteroduplex polynucleotide from two non-identical polynucleotides; introducing a nick in one strand at or near a base pair mismatch site; removing mismatched base(s) from the mismatch site where the nick occurred; and using the opposite strand as template to replace the removed base(s) with bases that complement base(s) in the first strand. By this method, information is transferred from one strand to the other at sites of mismatch.
    Type: Application
    Filed: October 10, 2003
    Publication date: July 22, 2004
    Inventors: Hal S. Padgett, Wayne P. Fitzmaurice, John A. Lindbo, Andrew A. Vaewhongs, Fakhrieh S. Vojdani, Mark L. Smith
  • Publication number: 20040110130
    Abstract: We describe here an in vitro method of redistributing sequence variations between non-identical polynucleotide sequences, by making a heteroduplex polynucleotide from two non-identical polynucleotides; introducing a nick in one strand at or near a base pair mismatch site; removing mismatched base(s) from the mismatch site where the nick occurred; and using the opposite strand as template to replace the removed base(s) with bases that complement base(s) in the first strand. By this method, information is transferred from one strand to the other at sites of mismatch.
    Type: Application
    Filed: October 25, 2002
    Publication date: June 10, 2004
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice
  • Publication number: 20040106198
    Abstract: The invention provides a system for expressing a foreign peptide in a plant cell, wherein the foreign protein is sensitive to a protease activity in the plant cell, by introducing into a plant cell a polynucleotide, which encodes the foreign protein and an another polynucleotide, which encodes a genetic element capable of reducing the protease activity in the plant cell. The invention also provides for plant cells, which incorporate this system, and for methods of reducing the proteolysis of the foreign protein expressed in a plant cell by using this system.
    Type: Application
    Filed: July 16, 2003
    Publication date: June 3, 2004
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Kathleen M. Hanley, Fakhrieh S. Vojdani, Long V. Nguyen, Wayne P. Fitzmaurice
  • Publication number: 20040060087
    Abstract: The present invention relates to novel interspecific Nicotiana excelsior×N. benthamiana hybrid seeds and plants and to a method of producing interspecific Nicotiana hybrids having enhanced properties for biomass and the production of recombinant proteins using a viral vector system.
    Type: Application
    Filed: September 18, 2003
    Publication date: March 25, 2004
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventor: Wayne P. Fitzmaurice
  • Publication number: 20040060086
    Abstract: The present invention relates to novel interspecific Nicotiana excelsior×N. benthamiana hybrid seeds and plants and to a method of producing interspecific Nicotiana hybrids having enhanced properties for biomass and the production of recombinant proteins using a viral vector system.
    Type: Application
    Filed: September 18, 2003
    Publication date: March 25, 2004
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventor: Wayne P. Fitzmaurice
  • Patent number: 6656726
    Abstract: The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183 kDa replicase proteins further characterized in its ability to stabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein, cells transformed with the vectors, and host plants infected by the viral vectors.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: December 2, 2003
    Assignee: Large Scale Biology Corporation
    Inventors: Wayne P. Fitzmaurice, Gregory P. Pogue, John A. Lindbo
  • Publication number: 20030186261
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3′ to 5′ exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Application
    Filed: July 25, 2002
    Publication date: October 2, 2003
    Applicant: Large Scale Biology Corporation
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice
  • Publication number: 20030157682
    Abstract: We describe here restriction endonucleases and their uses. Restriction endonucleases are useful in finding single nucleotide polymorphisms. They are also useful in an in vitro method of redistributing sequence variations between non-identical polynucleotide sequences.
    Type: Application
    Filed: January 31, 2003
    Publication date: August 21, 2003
    Inventors: Hal S. Padgett, Andrew A. Vaewhongs, Fakhrieh S. Vojdani, Mark L. Smith, John A. Lindbo, Wayne P. Fitzmaurice
  • Publication number: 20030036641
    Abstract: The invention provides methods of forcing recombination between polynucleotides. The methods can include the steps of, (a) generating a single strand of a first polynucleotide; (b) generating a single strand of a second polynucleotide, wherein the second polynucleotide is partially complementary to the first polynucleotide; (c) fragmenting the single strand of the first polynucleotide to generate single stranded first polynucleotide fragments; (d) fragmenting the single strand of the second polynucleotide to generate single stranded second polynucleotide fragments; (e) annealing the single stranded first polynucleotide fragments with the single stranded second polynucleotide fragments; and (f) extending the annealed polynucleotide fragments.
    Type: Application
    Filed: January 31, 2001
    Publication date: February 20, 2003
    Inventors: Hal S. Padgett, Wayne P. Fitzmaurice, John A. Lindbo
  • Publication number: 20030027173
    Abstract: The present invention provides methods for rapidly determining the function of nucleic acid sequences by transfecting the same into a host organism to effect expression. Phenotypic and biochemical changes produced thereby are then analyzed to ascertain the function of the nucleic acids which have been transfected into the host organism. The invention also provides methods for silencing endogenous genes by transfecting hosts with nucleic acid sequences to effect expression of the same. The present invention also provides methods for selecting desired functions of RNAs and proteins by the use of virus vectors to express libraries of nucleic acid sequence variants. Moreover, the present invention provides methods for inhibiting an endogenous protease of a plant host.
    Type: Application
    Filed: February 5, 2002
    Publication date: February 6, 2003
    Inventors: Guy Della-Cioppa, Robert L. Erwin, Wayne P. Fitzmaurice, Kathleen Hanley, Monto H. Kumagai, John A. Lindbo, David R. McGee, Hal S. Padgett, Gregory P. Pogue
  • Publication number: 20020177160
    Abstract: We describe here an in vitro method of increasing complementarity in a heteroduplex polynucleotide sequence. The method uses annealing of opposite strands to form a polynucleotide duplex with mismatches. The heteroduplex polynucleotide is combined with an effective amount of enzymes having strand cleavage activity, 3′ to 5′ exonuclease activity, and polymerase activity, and allowing sufficient time for the percentage of complementarity to be increased within the heteroduplex. Not all heteroduplex polynucleotides will necessarily have all mismatches resolved to complementarity. The resulting polynucleotide is optionally ligated. Several variant polynucleotides result. At sites where either of the opposite strands has templated recoding in the other strand, the resulting percent complementarity of the heteroduplex polynucleotide sequence is increased. The parent polynucleotides need not be cleaved into fragments prior to annealing heterologous strands. Therefore, no reassembly is required.
    Type: Application
    Filed: July 25, 2002
    Publication date: November 28, 2002
    Applicant: Large Scale Biology Corporation
    Inventors: Hal S. Padgett, John A. Lindbo, Wayne P. Fitzmaurice